Načítá se...
Intralesional collagenase Clostridium histolyticum in the management of Peyronie’s disease: current best practice
The use of Clostridium histolyticum collagenase (CCH) has become increasingly widespread for the treatment of Peyronie’s disease (PD) in recent years. Numerous trials have confirmed both its safety and efficacy in appropriately selected patients with this condition. The purpose of this review is to...
Uloženo v:
| Vydáno v: | Ther Adv Urol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5851106/ https://ncbi.nlm.nih.gov/pubmed/29560030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287218755020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|